Cure My Disease

Don't miss your cure!

 Log in / Sign up

New CAR-T therapy offers hope for children with hard-to-treat leukemia and lymphoma

NCT ID NCT04544592

Recruiting now Disease control Sponsor: University of Colorado, Denver Source: ClinicalTrials.gov ↗

First seen Apr 24, 2026 · Last updated May 16, 2026 · Updated 5 times

Summary

This study tests a new type of immune cell therapy (CAR-T) for children and teens whose B-cell leukemia or lymphoma has come back or not responded to standard treatments. The therapy uses the patient's own immune cells, modified to target and kill cancer cells. The goal is to see if this locally made treatment is safe and effective, and to include patients who were previously unable to receive such therapy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Children's Hospital Colorado

    RECRUITING

    Aurora, Colorado, 80045, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA B-CELL NON HODGKIN LYMPHOMA B-CELL NON HODGKIN LYMPHOMA